Alcobra's IPO

Alcobra raised a round of funding on November 17, 2015. Investors include Public.

Alcobra is a pharmaceutical company committed to developing safe and effective products for the treatment of cognitive disorders including ADHD and Fragile X Syndrom.…

Articles about Alcobra's IPO: